当前位置： SCI文献检索 > Expert Review of Pharmacoeconomics & Outcomes Research期刊下所有文献 > Metastatic melanoma in the older patient: immunologic insights and treatment outcomes.

Metastatic melanoma in the older patient: immunologic insights and treatment outcomes.

Abstract：

:Cutaneous melanoma (CM) is a highly curable skin cancer of melanocytes if diagnosed early. Unfortunately, its invasion into the deeper dermis increases the risk of it spreading to the lymph nodes and distant organs. Spread of metastatic melanoma (MM) to other organs is among one of the most dangerous conditions that is almost uniformly fatal for the majority of patients with the currently available treatment modalities. Since melanoma is an immunogenic tumor, developing novel immune strategies will continue to play a critical role in designing effective treatment modalities for those at high risk of recurrence and those with distant metastasis. While older age is believed to be a poor prognostic marker for CM, rapid expansion of the aging population and its projected increase in the coming decades is expected to result in a large number of elderly melanoma patients seeking treatment in all stages of disease. This will not only bring with it unique management challenges in this population, but also an increased burden on communities to provide financial and social resources. Comprehensive efforts will need to be directed towards early diagnosis, as well as developing safe and effective treatment. Renewed interest in the cancer immune surveillance theory coupled with recognition of aging-associated weaknesses in the immune system has put the spotlight on immunsenescence as a important risk factor for the rising incidence of CM in the aging population. Comprehensive assessment of the aging immune system might shed light, not only on weaknesses of individual components of the adaptive immune system, but also on the critical imbalances resulting from these weaknesses on anti-melanoma immunity. Identifying these imbalances might help harness novel immune-based treatment of MM in selected elderly patients. This article describes our experience of treating elderly patients with MM and the issues unique to them, with particular emphasis on insights into the aging immune system.

journal_name

Expert Rev Pharmacoecon Outcomes Res

journal_title

Expert review of pharmacoeconomics & outcomes research

authors

Hegde UP,Chakraborty N,Mukherji B,Grant Kels JM

doi

10.1586/erp.11.14

subject

Has Abstract

pub_date

2011-04-01 00:00:00

pages

185-93

issue

eissn

1473-7167

issn

1744-8379

journal_volume

pub_type

杂志文章,评审

在线工具

Metastatic melanoma in the older patient: immunologic insights and treatment outcomes.